A Novel Humanized Lethal Mouse Model of SARS‐CoV‐2‐Associated Disease
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Shannon Stone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Disease Models, Animal, COVID-19, SARS-CoV-2, Angiotensin-Converting Enzyme 2. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Mice are valuable small animal models for studying SARS‐CoV‐2 pathogenesis. Ancestral SARS‐CoV‐2 strains do not efficiently utilize murine Ace2 , rendering wild‐type mice resistant to infection. Although human ACE2 transgenic models such as K18‐hACE2 have provided critical insights, they express multiple copies of both murine and human ACE2, and random transgene insertion can result in non‐physiological receptor expression. To overcome these limitations, we employed a human ACE2 knock‐in (hACE2‐KI) model in which the murine Ace2 coding sequence is replaced with human ACE2 using CRISPR/Cas9 technology, generating an mAce2‐null background. This design allows human ACE2 expression under endogenous regulatory control while eliminating murine Ace2 expression, thereby providing a more physiologically relevant platform to investigate SARS‐CoV‐2 pathogenesis and evaluate therapeutic and preventive strategies. In this study, SARS‐CoV‐2‐associated disease was evaluated and compared among hACE2‐KI, K18‐hACE2 and C57BL/6J mice. Mice were intranasally inoculated with 10 5 plaque‐forming units of SARS‐CoV‐2 lineages B.1 or B.1.351. Both hACE2‐KI and K18‐hACE2 mice developed severe disease after SARS‐CoV‐2 infection. Following infection with B.1, both K18‐hACE2 mice and hACE2‐KI mice exhibited significant weight loss and mortality, with high viral loads detected in the lungs and brain. hACE2‐KI mice infected with SARS‐CoV‐2 B.1.351 also showed significant weight loss and viral loads, resulting in high mortality. The pathology and inflammatory response within the lungs and brain of infected hACE2‐KI mice revealed robust expression of viral nucleocapsid protein, histopathological changes, and upregulated cytokine and chemokine responses. Together, these findings demonstrate that the hACE2‐KI knock‐in mouse model supports robust SARS‐CoV‐2 replication and mimics severe COVID‐19 disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, Georgia, USA.
- Envigo, an Inotiv Company, GEMS R&D Group, St. Louis, Missouri, USA.
ORCID-Profile: Shannon Stone, Mukesh Kumar
Zitieren
APA
Stone, S., Elsharkawy, A., Patterson, L. D., Natekar, J. P., Jiang, H., Viktoria Hyddmark, E., Camarillo, J., Zhao, G., & Kumar, M. (2026). A Novel Humanized Lethal Mouse Model of SARS‐CoV‐2‐Associated Disease. Journal of Medical Virology. https://doi.org/10.1002/jmv.70959
Vancouver
Stone S, Elsharkawy A, Patterson LD, Natekar JP, Jiang H, Viktoria Hyddmark E, et al. A Novel Humanized Lethal Mouse Model of SARS‐CoV‐2‐Associated Disease. Journal of Medical Virology. 2026. doi:10.1002/jmv.70959
BibTeX
@article{Stone2026,
author = {Stone, Shannon and Elsharkawy, Amany and Patterson, Lila D and Natekar, Janhavi P and Jiang, Hongmei and Viktoria Hyddmark, E and Camarillo, Jeannie and Zhao, Guojun and Kumar, Mukesh},
title = {A Novel Humanized Lethal Mouse Model of SARS‐CoV‐2‐Associated Disease},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70959}
}
EUVIMED